insights_auto
Why is AGIO down 3,23%?
Dive Deeperchevron_right
AGIO:NASDAQ
Agios Pharmaceuticals Inc
31,76 USD
arrow_downward
-3,23%(-1,06) 1D
31,76 USD
0,00% (0,00)
bedtimeAfter hours
Closed: 12-ноя., 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
32,56 USD
High
32,76 USD
Low
31,56 USD
Mkt. cap
1,90 млд
Avg. vol.
1,29 млн
Volume
0,00
52-wk high
45,99 USD
52-wk low
22,24 USD
EPS
-6,32 USD
Beta
0,66
Shares outstanding
59,81 млн
No. of employees
540
Open
32,56 USD
High
32,76 USD
Low
31,56 USD
Mkt. cap
1,90 млд
Avg. vol.
1,29 млн
Volume
0,00
52-wk high
45,99 USD
52-wk low
22,24 USD
EPS
-6,32 USD
Beta
0,66
Shares outstanding
59,81 млн
No. of employees
540
News stories
From web sources and news partners
marketscreener.com
·
1 саат мурун
S&P 500 index fell after the Stockholm market closed Thursday
BeInCrypto
·
9 саат мурун
S&P 500 Recovered $1 Trillion in 90 Minutes Despite Wider Market Crash
TradingView
·
3 саат мурун
Dow, S&P 500, Nasdaq Futures Edge Higher As Markets Attempt To Recover From Nvidia Rout: SLS, MSFT, CADL, MSTR In Focus
Traders Union
·
8 саат мурун
Jake Wujastyk: S&P 500 and ES_F trade within last Thursday's range for a full week
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc